Recruiting for a Randomized Clinical Trial for Late-Life Depression During COVID-19: Outcomes of Provider Referrals Versus Facebook Self-Referrals

被引:1
|
作者
Ainsworth, Nicholas J.
Wright, Hailey
Tereshchenko, Ksenya
Blumberger, Daniel M.
Flint, Alastair J.
Lenze, Eric J.
Perivolaris, Athina
Mulsant, Benoit H.
机构
[1] Ctr Addict & Mental Hlth, Toronto, ON, Canada
[2] Univ Toronto, Temerty Fac Med, Dept Psychiat, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON, Canada
[4] Washington Univ, Dept Psychiat, Sch Med St Louis, St Louis, MO USA
来源
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
Depression; aging; clinical research; virtual care; COVID-19;
D O I
10.1016/j.jagp.2023.01.021
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To evaluate the effectiveness of online recruitment for a clinical trial of pharmacotherapy for late-life depression during COVID-19. Methods: The authors calculated the yield, defined as recruitment leading to randomization (enrollment), from provider referrals versus Facebook self-referrals; compared characteristics and drop-out rates of participants from each source; and ana-lyzed correlations between stringency of public health restrictions and referrals from each source over time. Results: Provider referrals had a significantly higher yield (10 of 33 referrals; 30.3%) versus Facebook self-referrals (14 of 323; 4.3%) (p <0.00001). Participants self-referred from Facebook had signifi-cantly more education; otherwise, both groups had similar characteristics and drop-out rates. While public health stringency was negatively correlated with provider referrals (r = -0.32) and positively correlated with Facebook self -referrals (r = 0.39), neither association reached statistical significance. Conclusion: Online recruitment may improve access to clinical research for older depressed adults. Future studies should evaluate cost-effectiveness and potential barriers such as computer literacy. (Am J Geriatr Psychiatry 2023; 31:366-371)
引用
收藏
页码:366 / 371
页数:6
相关论文
共 25 条
  • [1] RECRUITING FOR A RANDOMIZED CLINICAL TRIAL FOR LATE-LIFE DEPRESSION DURING COVID-19: OUTCOMES OF PROVIDER REFERRALS VS. FACEBOOK SELF-REFERRALS
    Ainsworth, Nicholas
    Tereschenko, Ksenya
    Blumberger, Daniel
    Flint, Alastair
    Lenze, Eric
    Mulsant, Benoit
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 31 (03): : S39 - S40
  • [2] Long-term outcomes of randomized clinical trial of collaborative care for late-life depression
    Hunkeler, E
    GERONTOLOGIST, 2004, 44 : 562 - 563
  • [3] Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic
    Zhao, Yuanzhi
    Wu, Xiangping
    Tang, Min
    Shi, Lingli
    Gong, Shuang
    Mei, Xi
    Zhao, Zheng
    He, Jiayue
    Huang, Ling
    Cui, Wei
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [4] Temporal Relations Among Emotional and Behavioral Factors in Late-Life Depression During the COVID-19 Pandemic
    Kazan, Joseph
    Gerlach, Andrew
    Mizuno, Akiko
    Aizenstein, Howard
    Stahl, Sarah
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 77 - 78
  • [5] Ontario healthcare workers who sought treatment for their mental health during the first five waves of the COVID-19 pandemic: a snapshot of self-referrals across the province
    Laposa, Judith M.
    Cameron, Duncan
    Corace, Kim
    Bullock, Heather L.
    Flavelle, Lauren
    Quick, Natalie
    Rowa, Karen
    de la Salle, Sara
    Creighton-Taylor, Katherin
    Strachan, Alice
    Carter, Stephanie
    Kurdyak, Paul
    Saldanha, Vanessa
    Mccabe, Randi E.
    HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION IN CANADA-RESEARCH POLICY AND PRACTICE, 2025, 45 (02):
  • [6] Forward-focused coping predicts better mental health outcomes in mid- to late-life during the COVID-19 pandemic
    Jordan, Leslie S.
    Woodard, John L.
    Pena, Gabriel S.
    Arnold-Nedimala, Naomi A.
    Won, Junyeon
    Callow, Daniel D.
    Smith, J. Carson
    AGING & MENTAL HEALTH, 2022, 26 (03) : 554 - 562
  • [7] Perceived Physical Health and Cognitive Behavioral Therapy vs Supportive Psychotherapy Outcomes in Adults With Late-Life Depression A Secondary Analysis of a Randomized Clinical Trial
    Dafsari, Forugh S.
    Bewernick, Bettina
    Boehringer, Sabine
    Domschke, Katharina
    Elsaesser, Moritz
    Loebner, Margrit
    Luppa, Melanie
    Schmitt, Sandra
    Wingenfeld, Katja
    Wolf, Elena
    Zehender, Nadine
    Hellmich, Martin
    Mueller, Wiebke
    Wagner, Michael
    Peters, Oliver
    Froelich, Lutz
    Riedel-Heller, Steffi
    Schramm, Elisabeth
    Hautzinger, Martin
    Jessen, Frank
    JAMA NETWORK OPEN, 2024, 7 (04) : E245841
  • [8] Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic:A Randomized Clinical Trial
    Back, Anthony L.
    Freeman-Young, Timara K.
    Morgan, Ladybird
    Sethi, Tanmeet
    Baker, Kelsey K.
    Myers, Susanna
    Mcgregor, Bonnie A.
    Harvey, Kalin
    Tai, Marlene
    Kollefrath, Austin
    Thomas, Brandon J.
    Sorta, Dennis
    Kaelen, Mendel
    Kelmendi, Benjamin
    Gooley, Ted A.
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [9] Accelerated Intermittent Theta Burst Stimulation in Late-Life Depression: A Possible Option for Older Depressed Adults in Need of ECT During the COVID-19 Pandemic
    Konstantinou, Gerasimos N.
    Downar, Jonathan
    Daskalakis, Zafiris J.
    Blumberger, Daniel M.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (10): : 1025 - 1029
  • [10] Late versus early administration of convalescent plasma in hospitalized patients with COVID-19: Results from the randomized open label clinical trial CAPSID
    Koerper, S.
    Weiss, M.
    Zickler, D.
    Wiesmann, T.
    Zacharowski, K.
    Corman, V. M.
    Gruener, B.
    Ernst, L.
    Spieth, P.
    Lepper, P. M.
    Bentz, M.
    Zinn, S.
    Paul, G.
    Kalbhenn, J.
    Dollinger, M.
    Rosenberger, P.
    Kirschning, T.
    Thiele, T.
    Appl, T.
    Mayer, B.
    Schmidt, M.
    Drosten, C.
    Wulf, H.
    Kruse, J. M.
    Jungwirth, B.
    Seifried, E.
    Schrezenmeier, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 118 - 118